Delivra Health Brands Inc (DHB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3,073 | 879 | 457 | 1,096 | N/A |
| Accounts receivable | 2,025 | -2,278 | -659 | 37 | N/A |
| Other Working Capital | -3,867 | -5,575 | -259 | -211 | -2 |
| Other Operating Activity | -19,590 | -12,990 | -10,646 | -4,944 | -33 |
| Operating Cash Flow | $-18,359 | $-19,964 | $-11,107 | $-4,022 | $-36 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,973 | -11,114 | -2,673 | -3,289 | N/A |
| Net Acquisitions | 1,349 | -5,814 | -16,822 | N/A | N/A |
| Purchase Sale Intangibles | -12 | -148 | -26 | -31 | N/A |
| Other Investing Activity | 10 | -250 | 0 | 100 | 0 |
| Investing Cash Flow | $-3,636 | $-17,326 | $-19,521 | $-3,219 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,500 | N/A | N/A | N/A | N/A |
| Debt Repayment | -334 | -40 | -2,134 | -493 | N/A |
| Common Stock Issued | N/A | 0 | 40,250 | 25,041 | N/A |
| Other Financing Activity | 0 | 800 | 35,106 | -3,940 | 0 |
| Financing Cash Flow | $3,166 | $760 | $73,222 | $20,607 | $N/A |
| Exchange Rate Effect | -66 | -15 | 6 | N/A | N/A |
| Beginning Cash Position | 20,301 | 56,846 | 14,246 | 880 | 48 |
| End Cash Position | 1,406 | 20,301 | 56,846 | 14,246 | 12 |
| Net Cash Flow | $-18,829 | $-36,530 | $42,594 | $13,366 | $-36 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,359 | -19,964 | -11,107 | -4,022 | -36 |
| Capital Expenditure | -6,315 | -11,262 | -2,699 | -3,320 | N/A |
| Free Cash Flow | -24,674 | -31,226 | -13,806 | -7,341 | -36 |